Initiator Pharma A/S reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was DKK 38.46 million compared to DKK 21.06 million a year ago. Basic loss per share from continuing operations was DKK 0.8 compared to DKK 0.6 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.95 SEK | +0.51% |
|
-3.40% | +7.68% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.68% | 50.31M | |
+35.20% | 51.51B | |
-6.94% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.69% | 26.13B | |
-14.23% | 19.91B | |
+43.20% | 13.71B | |
+30.69% | 12.38B | |
-4.42% | 11.74B |
- Stock Market
- Equities
- INIT Stock
- News Initiator Pharma A/S
- Initiator Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2022